Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2017 May 9;26(7):819–826. doi: 10.1002/pds.4224

Table 1.

Characteristics of study population (n=770,095)

Factors Receipt of Industry Payments
N (%)
P value1
Yes
N=292,763 (38.0)
No
N=477,332 (62.0)
Prescriber characteristics
 Sex <.0001
  Male 216,798 (74.0) 251,536 (52.7)
  Female 75,965 (26.0) 225,796 (47.3)
 Region <.0001
  Northeast 60,513 (20.7) 108,699 (22.8)
  Midwest 60,674 (20.7) 107,089 (22.4)
  South 116,745 (39.9) 153,182 (32.1)
  West 52,521 (17.9) 105,483 (22.1)
  Non-US 2,310 (0.8) 2,879 (0.6)
Prescriber practice factors
 Specialty <.0001
  Primary care 99288 (33.9) 131,968 (27.7)
  Medical specialty 69,053 (23.6) 33,662 (7.1)
  Surgical specialty 45,631 (15.6) 28,536 (6.0)
  Obstetrics/gynecology 16,888 (5.8) 11,640 (2.4)
  Hospital-based specialty 15,460 (5.3) 34,800 (7.3)
  Psychiatry 15,786 (5.4) 18,248 (3.8)
  Non-physician, unknown 30,657 (10.5) 218,478 (45.8)
 Annual number of distinct Medicare Part D beneficiaries served <.0001
  0-50 59,427 (20.3) 190,733 (40.0)
  51-100 46,474 (15.9) 93,833 (16.7)
  101-250 88,855 (30.4) 127,402 (26.7)
  251 and above 98,007 (33.5) 65,364 (13.7)
 Annual number of Medicare Part D claims <.0001
  0-100 35,213 (12.0) 128,023 (26.8)
  101-400 67,191 (23.0) 157,545 (33.0)
  401-2000 88,509 (30.2) 118,972 (24.9)
  2001 and above 101,850 (34.8) 72,792 (15.3)
1

Chi-square tests